| Fri, Feb 5, 2010 |
| • |
UPDATE - AVI genetic disorder drug gets orphan status in EU
at Reuters (Fri, Feb 5)
|
| • |
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy
Marketwire (Fri, Feb 5)
|
| Thu, Feb 4, 2010 |
| • |
AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicology
Marketwire (Thu, Feb 4)
|
| Tue, Jan 19, 2010 |
| • |
AVI BIOPHARMA INC Files SEC form 8-K, Other Events
EDGAR Online (Tue, Jan 19)
|
| Mon, Jan 11, 2010 |
| • |
3 Stocks Hitting High Notes
at Motley Fool (Mon, Jan 11)
|
| Wed, Dec 23, 2009 |
| • |
AVI BIOPHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Wed, Dec 23)
|
| Tue, Dec 22, 2009 |
| • |
Systemic Treatment With AVI-4658 Demonstrates RNA Exon Skipping and Dystrophin Protein Expression in Duchenne Muscular Dystrophy Patients
Marketwire (Tue, Dec 22)
|
| Thu, Nov 19, 2009 |
| • |
AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
Marketwire (Thu, Nov 19)
|
| Wed, Nov 18, 2009 |
| • |
AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day
Marketwire (Wed, Nov 18)
|
| Fri, Nov 13, 2009 |
| • |
AVI BIOPHARMA INC Financials
EDGAR Online Financials (Fri, Nov 13)
|
| Mon, Nov 9, 2009 |
| • |
AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate Highlights
Marketwire (Mon, Nov 9)
|
| • |
AVI BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
EDGAR Online (Mon, Nov 9)
|
| Mon, Nov 2, 2009 |
| • |
AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call
Marketwire (Mon, Nov 2)
|
| Mon, Oct 26, 2009 |
| • |
AVI BioPharma Presents Updated Safety Data From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
Marketwire (Mon, Oct 26)
|
| Fri, Oct 23, 2009 |
| • |
4-Star Stocks on the Upswing
at Motley Fool (Fri, Oct 23)
|
| Thu, Oct 22, 2009 |
| • |
AVI BioPharma to Present Safety Update From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
Marketwire (Thu, Oct 22)
|
| Tue, Oct 20, 2009 |
| • |
Exon Skipping Drug Prevents Muscle Wasting and Maintains Muscle Function in Severely Affected, Dystrophin Deficient Mice
Marketwire (Tue, Oct 20)
|
| Mon, Oct 19, 2009 |
| • |
Exon Skipping Therapy Shows Promise in Prevention or Delay of Heart Disease Associated With Duchenne Muscular Dystrophy
Marketwire (Mon, Oct 19)
|
| Thu, Oct 8, 2009 |
| • |
4-Star Stocks on the Upswing
at Motley Fool (Thu, Oct 8)
|
| Tue, Oct 6, 2009 |
| • |
AVI BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, Oct 6)
|
| Older Headlines |
|
|
|
|
Help
Headlines
